Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ot;Popgun Gonna play it by ear...........eom
Congrats, Hinchback and Jochef....eom
briefly.......
There's your print!!!
Looks like the old gangs back in town!!! Lets rock Baby!!!
I'll second that!!!! eom
See ya Drift Happy Holidays........eom
I've been buying all day, first @.0194, yea thats me, They don't call me H O D Hogan54 for nothin'. lol
Good morning all..Happy birthday Cabroncita..eom
Good morning all...bid building.eom
REMINDER............
Sickle cell anemia, one of the world’s major enduring medical mysteries afflicting people of African descent, may have finally met its match in hemoXiN/NiCosAN, a new plant-derived treatment produced by the medical firm Xechem International. While Western pharmaceuti cal companies have invested billions in the search for an effective remedy for the blood disorder, Xechem teamed with researchers and traditional healers in Nigeria to perfect a combination of four indigenous plants which com bat the symptoms of the disease.
Helmed by Dr. Ramesh C. Pandey, a 40-year veteran of research into traditional Indian and Chinese phytopharmaceuticals, or nature-derived drugs, Xechem International has been a pioneer in the investi gation of natural and folkloric remedies since 1994. For the last five years however, the company has mobilized its efforts to focus on alleviating sickle cell symptoms. “We are working hard to bring NICOSAN/HEMOXIN to market initially in Nigeria and subsequently in the United States and other countries,” said Dr. Pandey. “The Nigerian market alone represents potential revenue in excess of $500,000,000 for the company.” In addition, Dr. Pan dey has been invited to participate in conferences and medical symposiums throughout eastern and southern Africa.
REMINDER......
U.S. Companies Add Jobs to Fill Export Order
WASHINGTON, Oct. 31 /PRNewswire/ -- Companies in Florida, Georgia and
Illinois are exporting equipment and services to a Nigerian pharmaceutical
firm to help it in the fight against sickle cell anemia.
The exports by American Plastics Technologies, Inc., Schiller Park,
Ill.; FinancialBridge, Inc., Miami, Fla.; Nitra Group, Aventura, Fla.; and
Fisher Scientific Co. LLC, Suwanee, Ga., are being made possible by a $9.3
million loan guarantee from the Export-Import Bank of the United States
(Ex-Im Bank). American Plastics Technologies and FinancialBridge both are
small businesses.
Xechem Pharmaceuticals Nigeria Limited, Abuja, Nigeria will use the
funds to build laboratories and a manufacturing plant in Abuja to develop a
variety of herbal-based drugs to combat sickle cell anemia
Ex-Im Bank approved the medium-term loan guarantee under its new $300
million financing facility, allocated among 14 Nigerian banks, to support
U.S. exports to Nigeria. The consolidated facility is designed to expedite
the processing of short- and medium-term Ex-Im Bank financing for the
purchase of U.S. goods and services by Nigerian buyers. This is the third
transaction to be supported by the facility.
UPS Capital Business Credit of Hartford, Conn. is the guaranteed lender
on the transaction. Two Nigerian banks included in the facility, Diamond
Bank Ltd., and Access Bank Nigeria Plc., both of Lagos, are supporting the
transaction by providing co-guarantees.
"This transaction will support the development of Nigeria's
pharmaceutical infrastructure and at the same time create and sustain U.S.
jobs at small and large businesses alike," said Ex-Im Bank Chairman and
President James H. Lambright. "We look forward to the continued use of this
financing facility to make possible exports to Nigeria that otherwise would
not go forward, and to foster growth in Nigeria's banking sector and a wide
range of Nigerian industries."
"In the past, European businesses have aggressively used government
assisted financing to successfully compete against us, even though their
prices are 40-50 percent higher than ours," said American Plastics CEO Dr.
Rao K. Murukurthy. "Now with the help of Ex-Im Bank, we are reversing this
trend and selling internationally. This project to build a pharmaceutical
factory in Nigeria helps us to employ about 25 technicians and engineers
for about eight months. It also helps several of our U.S. vendors to employ
about 25 workers for six to eight months."
"Helping U.S. companies win global business is important to UPS Capital
and in this transaction, four U.S. companies, including two U.S. small
businesses, will be supported by the Export-Import Bank of the United
States," said Jim Fortsch, head of ECA Finance at UPS Capital. "Since the
funds provided by UPS Capital will be used to purchase plant equipment and
machinery for a state-of-the art pharmaceutical facility, this project is
especially rewarding."
Xechem, a wholly owned international subsidiary of Xechem
International, Inc., New Brunswick, N.J., is building the pharmaceutical
facilities under an agreement with Nigeria's National Institute for
Pharmaceutical Research and Development and Nigeria's Ministry of Health.
U.S. exporters interested in learning more about Ex-Im Bank's Nigerian
bank financing facility and how it can be used to support sales of U.S.
goods and services to Nigeria may contact the nearest Ex-Im Bank regional
office by calling 1-800-565-3946 and selecting option 2. Visit Ex-Im Bank's
web site at http://www.exim.gov.
Ex-Im Bank this year marks its 72nd year of helping finance the sale of
U.S. exports, primarily to emerging markets throughout the world. The Bank
works with commercial lenders to help U.S. companies increase export sales
and American jobs and minimize risk by accessing Ex-Im Bank financing and
export credit insurance.
OT I watched NNVC go from .03 to 3.50 in three mos. with no bird flu vaccine whatsoever!!!
.50 to 1.00 in a year.........IMO
Yes and ARCA needs to move on!!!! eom
Lunch time???.......eom
Bought 96,500 @ .0205.....eom
I suspect the new facility, when in full production, will be working 24/7 to meet demand for nicosan.IMO
Good morning all...
carcel........jajajajajajaja
lol... oil on that hip replacement!!!
oilstrike..welcome back...
Good morning all....eom
Good read transam... help is on the way for those good folks!!!IMO
Well done Fox......
At roughly .70 cents per pill, thats a lot of money!!!
Thanks trazbull
Does anyone know or care to speculate, when the new facility is in full production mode, how many pills they could produce daily? painkiller doc, anyone??
Lets fill the damn gap and get the hell out of here!!!
wireliner..now that makes sense!
Welcome back hinch......
Big d...great idea!!
OT...Pfizer(pfe) dropping like a ton of bricks!!!
These MM's would steal the dimes out of a dead mans eyes....eom
Gut check time!!! Hang tough...
Good morning all...
Adios my friends.......party time!!!!
Plead.........
OT...Someone said the "Devil" made him do it, of whom he is incarcerated with, gotta get him out! Must be hell in there!